HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Li Selected Research

Pyrogens

8/2001Cyclooxygenase-2 mediates the febrile response of mice to interleukin-1beta.
1/2001Differential inhibition by nimesulide of the early and late phases of intravenous- and intracerebroventricular-LPS-induced fever in guinea pigs.
12/2000Pyrogenic signaling via vagal afferents: what stimulates their receptors?
10/2000Pyrogen sensing and signaling: old views and new concepts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Li Research Topics

Disease

133Neoplasms (Cancer)
06/2022 - 03/2000
30Infections
11/2021 - 01/2000
24Inflammation (Inflammations)
01/2021 - 01/2000
22Neoplasm Metastasis (Metastasis)
12/2021 - 10/2000
20Breast Neoplasms (Breast Cancer)
09/2021 - 06/2000
18Fibrosis (Cirrhosis)
11/2021 - 01/2000
15Carcinoma (Carcinomatosis)
01/2020 - 09/2000
13Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022 - 05/2005
12Body Weight (Weight, Body)
12/2021 - 10/2001
12Lung Neoplasms (Lung Cancer)
08/2021 - 02/2000
12Carcinogenesis
09/2019 - 05/2000
12Ischemia
07/2019 - 03/2000
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 12/2001
11Fever (Fevers)
07/2021 - 03/2000
11Hypoxia (Hypoxemia)
01/2018 - 08/2000
10Stomach Neoplasms (Stomach Cancer)
03/2022 - 12/2012
10Leukemia
01/2017 - 03/2001
10Necrosis
09/2014 - 01/2000
9Reperfusion Injury
07/2019 - 09/2004
9Prostatic Neoplasms (Prostate Cancer)
06/2019 - 10/2000
9Melanoma (Melanoma, Malignant)
01/2016 - 04/2002
8Thrombosis (Thrombus)
03/2022 - 04/2000
8Pain (Aches)
01/2022 - 09/2004
8Type 2 Diabetes Mellitus (MODY)
12/2021 - 09/2000
8Hypertension (High Blood Pressure)
07/2021 - 01/2001
8Pneumonia (Pneumonitis)
06/2021 - 04/2000
8Hepatocellular Carcinoma (Hepatoma)
06/2021 - 08/2000
8Osteosarcoma (Osteogenic Sarcoma)
09/2020 - 01/2000
8Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 01/2009
8Cardiovascular Diseases (Cardiovascular Disease)
05/2019 - 03/2001
7Adenocarcinoma
09/2021 - 10/2005
7BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2016 - 03/2001
6Colorectal Neoplasms (Colorectal Cancer)
12/2020 - 09/2000
6Stroke (Strokes)
01/2020 - 07/2006
6Wounds and Injuries (Trauma)
05/2019 - 04/2008
6Insulin Resistance
08/2017 - 09/2000
6Hemorrhage
06/2017 - 01/2000
6Multiple Sclerosis
01/2017 - 03/2000
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2012 - 12/2000
5Chronic Obstructive Pulmonary Disease (COPD)
08/2021 - 05/2009
5Coronary Artery Disease (Coronary Atherosclerosis)
01/2021 - 08/2012
5Thyroid Neoplasms (Thyroid Cancer)
03/2020 - 09/2001
5Ischemic Stroke
01/2020 - 08/2012
5Glioma (Gliomas)
10/2019 - 07/2000
5Atherosclerosis
11/2018 - 08/2011
5Diabetes Mellitus
04/2018 - 06/2000
5Hepatitis
08/2017 - 12/2000
5Asthma (Bronchial Asthma)
01/2016 - 09/2000
5Esophageal Neoplasms (Esophageal Cancer)
11/2015 - 07/2000
5Squamous Cell Carcinoma of Head and Neck
10/2015 - 09/2000

Drug/Important Bio-Agent (IBA)

53Proteins (Proteins, Gene)FDA Link
06/2022 - 05/2000
27Messenger RNA (mRNA)IBA
09/2021 - 01/2000
21DNA (Deoxyribonucleic Acid)IBA
12/2021 - 07/2000
19Pharmaceutical PreparationsIBA
08/2019 - 04/2000
17MicroRNAs (MicroRNA)IBA
10/2020 - 09/2013
16Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2003
16CytokinesIBA
10/2020 - 10/2000
15EnzymesIBA
08/2020 - 03/2000
13AntigensIBA
02/2021 - 01/2000
12LipidsIBA
12/2021 - 10/2001
12Biological ProductsIBA
08/2021 - 02/2000
11RNA (Ribonucleic Acid)IBA
01/2022 - 12/2000
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2020 - 03/2001
11Phosphotransferases (Kinase)IBA
01/2020 - 01/2009
10Long Noncoding RNAIBA
12/2021 - 01/2016
10Glucose (Dextrose)FDA LinkGeneric
09/2020 - 09/2000
9VaccinesIBA
08/2020 - 08/2001
9Cisplatin (Platino)FDA LinkGeneric
08/2019 - 12/2001
9CollagenIBA
01/2018 - 01/2000
8ErbB Receptors (EGF Receptor)IBA
12/2021 - 05/2000
8Estrogens (Estrogen)FDA Link
08/2019 - 03/2000
8AntibodiesIBA
05/2019 - 01/2000
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2014 - 09/2000
7Reactive Oxygen Species (Oxygen Radicals)IBA
12/2021 - 07/2000
7LigandsIBA
08/2021 - 05/2001
7Transcription Factors (Transcription Factor)IBA
08/2021 - 11/2011
7Ustekinumab (CNTO 1275)FDA Link
10/2020 - 04/2011
7Insulin (Novolin)FDA Link
08/2017 - 09/2000
7Small Interfering RNA (siRNA)IBA
01/2017 - 11/2007
7AcidsIBA
05/2015 - 10/2000
6Indicators and Reagents (Reagents)IBA
01/2022 - 12/2001
6Complement System Proteins (Complement)IBA
12/2021 - 03/2000
6Interleukin-6 (Interleukin 6)IBA
11/2016 - 06/2002
6Estrogen ReceptorsIBA
01/2016 - 12/2000
6Complementary DNA (cDNA)IBA
07/2015 - 07/2000
6CholesterolIBA
09/2012 - 01/2000
6Estrogen Receptor alphaIBA
12/2008 - 06/2000
6Coloring Agents (Dyes)IBA
09/2001 - 01/2000
5Metformin (Glucophage)FDA LinkGeneric
11/2022 - 08/2014
5CreatinineIBA
07/2021 - 12/2000
5LipopolysaccharidesIBA
01/2021 - 01/2001
5Therapeutic UsesIBA
09/2020 - 02/2001
5CateninsIBA
09/2019 - 09/2013
5Monoclonal AntibodiesIBA
01/2018 - 05/2000

Therapy/Procedure

48Therapeutics
03/2022 - 03/2000
16Radiotherapy
12/2020 - 03/2001
11Drug Therapy (Chemotherapy)
10/2021 - 04/2000
11Transplantation
10/2020 - 03/2000
8Aftercare (After-Treatment)
02/2020 - 09/2006
6Ligation
12/2022 - 06/2000